Showing results (271-280 of 281) with videos related to
Sort By:
Pageof 29
Cancer Letters|June 2, 2009
E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancerXiao-Ping He, Chang-Qing Su, Xing-Hua Wang, et al.Chinese Medical Journal|August 31, 2012
Gastro-protecting effect of gefarnate on chronic erosive gastritis with dyspeptic symptomsYi-Qi DU, Tun Su, Jian-Yu Hao, et al.World Journal of Gastroenterology|September 22, 2010
Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitisXiang-Yu Kong, Yi-Qi Du, Lei Li, et al.Journal of Cellular and Molecular Medicine|November 26, 2016
A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentationDing'an Zhou, Zhiyun Wei, Zhongshu Kuang, et al.Cancer Immunology Research|August 29, 2020
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal CancerZhi Peng, Siyuan Cheng, Yan Kou, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2021
pH and Proton Sensor GPR65 Determine Susceptibility to Atopic DermatitisLiang Xie, Craig I McKenzie, Xinyan Qu, et al.Oncotarget|February 5, 2017
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I studyJian Ming Xu, Yan Wang, Yu Ling Chen, et al.Plos Pathogens|October 7, 2021
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosusPengcheng Zhou, Jiali Chen, Jing He, et al.Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.Annals of Translational Medicine|June 23, 2020
A follow-up study of children infected with SARS-CoV-2 from western ChinaHongmei Xu, Enmei Liu, Jun Xie, et al.Pageof 29